Clinical trial Recruiting at 6 sites Interventional Ages 18 and up

Left bundle branch area pacing versus conventional right‑ventricular pacing after TAVI for atrioventricular block

Official title: Prospective Multicenter Randomized Controlled Trial Evaluating the Benefit of Left Bundle Branch Area Stimulation Compared With Conventional Pacing in Post-TAVI Atrioventricular Atrioventricular Block

Run by Nantes University Hospital · NCT07236489 · Data updated 2026-11-12

This will test whether left bundle branch area pacing works better than standard right‑ventricular pacing for people who need a pacemaker after TAVI.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment266 (estimated)
SponsorNantes University Hospital
Academic / other
Locations7 sites (Brest, Finistère and 6 other locations)
StatusRecruiting
StartedNovember 25, 2025
Main results expectedNovember 2029
Study endsNovember 2029
Registry record updatedApril 15, 2026
Trial IDNCT07236489 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients within three months of TAVI who have preserved LVEF (≥50%) and a guideline indication for pacemaker implantation such as third‑degree AV block, Mobitz II or symptomatic Mobitz I block, alternating bundle branch block, HV interval ≥70 ms, or new/worsening conduction disturbances after TAVI.

Probably not a fit

Patients with LVEF below 50% before TAVI, those with a prior pacemaker, or those with contraindications to endocardial pacemaker implantation are unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study enrolls patients who develop atrioventricular block within three months after transcatheter aortic valve implantation and have preserved left ventricular ejection fraction. Participants meeting guideline indications for pacemaker implantation will receive either left bundle branch area pacing or conventional right‑ventricular pacemaker implantation at participating centers. Clinical and echocardiographic outcomes such as changes in LVEF, heart failure hospitalizations, and mortality will be compared during follow‑up. The intent is to see if physiological conduction via left bundle branch area pacing reduces pacing‑induced dyssynchrony and downstream complications compared with standard pacing.

Why it matters

Potential benefit: If successful, this approach could better preserve normal ventricular activation, reduce heart failure events, and help maintain left ventricular function in patients needing pacemakers after TAVI.

How similar studies have gone: Retrospective and observational studies have suggested clinical and physiological benefits of left bundle branch area pacing, but prospective randomized evidence is limited or lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who have undergone TAVI for severe aortic valve disease within the past 3 months
* Preserved left ventricular ejection fraction (LVEF ≥ 50%)
* Indications for pacemaker implantation according to guidelines, including :
* Third-degree atrioventricular (AV) block
* Second-degree AV block Mobitz type 2 or symptomatic Mobitz type 1
* Alternating left and right bundle branch block
* HV interval ≥ 70 ms during electrophysiological study
* Pre-existing right bundle branch block with worsening conduction disturbances post-TAVI
* Prolongation of QRS and PR intervals post-procedure justifying pacemaker implantation
* Signed informed consent
* Patient affiliated with the national health insurance system

Exclusion Criteria:

* Left ventricular ejection fraction (LVEF) \< 50% before TAVI
* Contraindication to implantation of an endocardial pacemaker (vascular access issues, sepsis)
* Previously implanted pacemaker
* Patients under legal guardianship, curatorship, or judicial protection
* Participation in another interventional therapeutic clinical trial

Where it's running

  • Brest University Hospital
    Brest, Finistère, France
    Recruiting
  • Rennes University Hospital
    Rennes, Ille-et-Vilaine, France
    Recruiting
  • Tours University Hospital
    Tours, Indre-et-Loire, France
    Recruiting
  • Nantes University Hospital
    Nantes, Loire-Atlantique, France
    Recruiting
  • Rouen University Hospital
    Rouen, Seine-Maritime, France
    Recruiting
  • Poitiers University Hospital
    Poitiers, Vienne, France
    Recruiting
Show 1 more location
  • Clermont Ferrand University Hospital
    Clermont-Ferrand, Puy-de-Dôme, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.